These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30518853)
1. Lecithin-Stabilized Polymeric Micelles (L Chang CE; Hsieh CM; Huang SC; Su CY; Sheu MT; Ho HO Sci Rep; 2018 Dec; 8(1):17640. PubMed ID: 30518853 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878 [TBL] [Abstract][Full Text] [Related]
3. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity. Cheng WJ; Lin SY; Chen M; Chen LC; Ho HO; Chuang KH; Sheu MT Int J Nanomedicine; 2021; 16():4017-4030. PubMed ID: 34140769 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. Cote B; Carlson LJ; Rao DA; Alani AWG J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305 [TBL] [Abstract][Full Text] [Related]
5. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Xu G; Shi H; Ren L; Gou H; Gong D; Gao X; Huang N Int J Nanomedicine; 2015; 10():2051-63. PubMed ID: 25844036 [TBL] [Abstract][Full Text] [Related]
6. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model. Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Li H; Li M; Fu J; Ao H; Wang W; Wang X Drug Deliv; 2021 Dec; 28(1):1226-1236. PubMed ID: 34142631 [TBL] [Abstract][Full Text] [Related]
9. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance. Yu J; Chen H; Jiang L; Wang J; Dai J; Wang J J Pharm Sci; 2019 May; 108(5):1788-1799. PubMed ID: 30610857 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834 [TBL] [Abstract][Full Text] [Related]
12. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141 [TBL] [Abstract][Full Text] [Related]
13. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles. Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698 [TBL] [Abstract][Full Text] [Related]
15. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity. Jain S; Jain AK; Pohekar M; Thanki K Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276 [TBL] [Abstract][Full Text] [Related]
16. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306 [TBL] [Abstract][Full Text] [Related]
17. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo. Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818 [TBL] [Abstract][Full Text] [Related]
18. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Choi JS; Piao YJ; Kang KW Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726 [TBL] [Abstract][Full Text] [Related]
19. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
20. Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles. Chen YC; Su CY; Jhan HJ; Ho HO; Sheu MT Int J Nanomedicine; 2015; 10():7265-74. PubMed ID: 26664117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]